Rociverine compared with other spasmolytics for cardiovascular effects.
D000818:Animals; D001794:Blood Pressure / Q000187:drug effects; D001643:Bridged Bicyclo Compounds / Q000494:pharmacology* / Q000633:toxicity; D001952:Bridged-Ring Compounds / Q000494:pharmacology*; D002086:Butylscopolammonium Bromide / Q000494:pharmacology; D002339:Carotid Arteries; D002560:Cerebrovascular Circulation / Q000187:drug effects; D003509:Cyclohexanecarboxylic Acids; D004025:Dicyclomine / Q000494:pharmacology; D004285:Dogs; D005260:Female; D006339:Heart Rate / Q000187:drug effects; D006439:Hemodynamics / Q000187:drug effects*; D008297:Male; D051379:Mice; D010208:Papaverine / Q000494:pharmacology; D010276:Parasympatholytics / Q000494:pharmacology*; D051381:Rats; D012119:Respiration / Q000187:drug effects
D001643:Bridged Bicyclo Compounds; D001952:Bridged-Ring Compounds; D003509:Cyclohexanecarboxylic Acids; D010276:Parasympatholytics; D002086:Butylscopolammonium Bromide; D004025:Dicyclomine; D010208:Papaverine; C021082:rociverine